Advanced therapies in Parkinson’s Disease

In cutting edge Parkinson's malady (PD), neurologists and patients confront an unpredictable choice for a propelled treatment. While picking a treatment, the best accessible proof ought to be joined with the expert's skill and the patient's inclinations. Objective: The target of this investigation was to investigate current basic leadership in cutting edge PD. Techniques: We led centre gathering exchanges and individual meetings with patients (N = 20) who had gotten profound cerebrum incitement, Levodopa-Carbidopa intestinal gel, or subcutaneous Apo morphine implantation, and with their guardians (N = 16).

  • Gene therapy
  • Neural Degeneration
  • Neuturin Gene Therapy for Parkinson’s disease
  • Surgical therapeutics for Parkinson’s disease
  • Neurotrophic Factor

Related Conference of Advanced therapies in Parkinson’s Disease

Advanced therapies in Parkinson’s Disease Conference Speakers